Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Re-Treatment Study of Probuphine in Opioid Addiction

ClinicalTrials.gov ID: NCT01262261

Public ClinicalTrials.gov record NCT01262261. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 12:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Six-Month, Open-Label, Re-Treatment Study of Probuphine in Opioid Addiction

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Probuphine (buprenorphine implant) is an investigational implant placed just below the skin containing buprenorphine (BPN). BPN is an approved treatment for opioid dependence. This is a 6-month, open-label, re-treatment study that will confirm the safety and efficacy of Probuphine in patients who have previously completed the 6-month PRO-806 study with either Probuphine, placebo or sublingual buprenorphine.

Study identification

NCT ID
NCT01262261
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Titan Pharmaceuticals
Industry
Enrollment
85 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2010 (Type not available)
Primary completion
Nov 2011 (Actual)
Completion
Nov 2011 (Actual)
Last update posted
Dec 31, 2018

2010 – 2011

United States locations

U.S. sites
18
U.S. states
12
U.S. cities
18
Facility City State ZIP Site status
David Geffen School of Medicine at UCLA Los Angeles California 90025 —
Synergy Clinical Research Center National City California 91950 —
North County Clinical Research Oceanside California 92056 —
Friends Research Institute Torrance California 90502 —
Amit Vijapura, MD Jacksonville Florida 32256 —
Operation PAR, Inc. - TC Campus Largo Florida 33771 —
Fidelity Clinical Research Lauderhill Florida 33319 —
Scientific Clinical Research, Inc. North Miami Florida 33161 —
BPRU, Behavioral Biology Research Center Baltimore Maryland 21224 —
Stanley Street Treatment and Resources, Inc Fall River Massachusetts 02720 —
Precise Research Centers Flowood Mississippi 39232 —
Psych Care Consultants Research St Louis Missouri 63128 —
St. Luke's Roosevelt Hospital Center New York New York 10025 —
Duke University Medical Center Durham North Carolina 27705 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
Carolina Clinical Trials, Inc. Charleston South Carolina 29407 —
University of Vermont Burlington Vermont 05401 —
Providence Behavioral Health Services Everett Washington 98201 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01262261, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 31, 2018 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01262261 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →